NovaBay Pharmaceuticals - 53 Year Dividend History | NBY
Historical dividend payout and yield for NovaBay Pharmaceuticals (NBY) since 1971. The current TTM dividend payout for NovaBay Pharmaceuticals (NBY) as of April 19, 2024 is $0.00. The current dividend yield for NovaBay Pharmaceuticals as of April 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.003B |
$0.015B |
|
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
